The Japanese Biochemical Society/The Molecular Biology Society of Japan

6:20 PM - 6:30 PM

[2PT26-15(3P-0899)] Investigation of novel anti-cancer drug using by alpha-Particle Emitting Radionuclides

〇Kazuko Kaneda1, Zi Jian Zhang1,2, Takumi Ikeda2, Akimitsu Kanda2, Souichiro Ichimura2, Yoshiyuki Manabe1,3, Atsushi Shimoyama1,3, Kazuya Kabayama1,3, Koujiro Nagata7, Tadashi Watabe1,4, Atsushi Toyoshima1,5, Yoshikatsu Kanai6, Takashi Yoshimura1,7, Mitsuhiro Fukuda1,8, Koichi Fukase1,3, Atsushi Shinohara1,2 (1.MS-CORE, PRC, Grad. Sch. of Sci., Osaka Univ., 2.Radiochem., Dept., of Chem., Grad. Sch. of Sci., Osaka Univ., 3.Natur. Prod. Chem., Dept., of Chem., Grad. Sch. of Sci., Osaka Univ., 4.Nucl. Med., Dept., Grad. Sch. of Med., Osaka Univ., 5.Heavy Element Nucl., ASRC, JAEA, 6.Bio-System Pharm., Dept., Grad. Sch. of Med., Osaka Univ., 7.RI research center, Osaka Univ., 8.Accelerator, RNCP, Osaka Univ.)

RI、cancer、Astatine-211、Alpha-Particle、molecular targeting

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password